HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hans-Christoph Diener Selected Research

Caffeine (No Doz)

12/2023Risk factors for migraine disease progression: a narrative review for a patient-centered approach.
10/2017Caffeine in the management of patients with headache.
10/2015New therapeutic approaches for the prevention and treatment of migraine.
9/2015Use of aspirin combinations with caffeine and increasing headache frequency: a prospective population-based study.
11/2014Use of a fixed combination of acetylsalicylic acid, acetaminophen and caffeine compared with acetaminophen alone in episodic tension-type headache: meta-analysis of four randomized, double-blind, placebo-controlled, crossover studies.
6/2014Influences of smoking and caffeine consumption on trigeminal pain processing.
2/2012Hypnic headache: clinical course and treatment.
4/2011Self-medication of migraine and tension-type headache: summary of the evidence-based recommendations of the Deutsche Migräne und Kopfschmerzgesellschaft (DMKG), the Deutsche Gesellschaft für Neurologie (DGN), the Österreichische Kopfschmerzgesellschaft (ÖKSG) and the Schweizerische Kopfwehgesellschaft (SKG).
12/2010Clinical characteristics and therapeutic options in hypnic headache.
5/2009OTC analgesics in headache treatment: open-label phase vs randomized double-blind phase of a large clinical trial.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hans-Christoph Diener Research Topics

Disease

154Stroke (Strokes)
04/2024 - 09/2001
97Migraine Disorders (Migraine)
11/2023 - 01/2002
78Ischemic Stroke
04/2024 - 09/2001
76Hemorrhage
04/2024 - 09/2001
72Atrial Fibrillation
01/2023 - 02/2005
62Headache (Headaches)
12/2023 - 01/2002
28Pain (Aches)
01/2021 - 01/2002
18Myocardial Infarction
05/2022 - 09/2001
18Embolism (Embolus)
01/2021 - 08/2004
16Intracranial Hemorrhages (Intracranial Hemorrhage)
12/2023 - 02/2006
16Cluster Headache (Cluster Headaches)
12/2022 - 07/2007
13Embolic Stroke
06/2022 - 08/2009
13Hypertension (High Blood Pressure)
01/2020 - 12/2003
13Transient Ischemic Attack
01/2019 - 09/2001
10Secondary Headache Disorders
01/2023 - 07/2007
9Prescription Drug Overuse
12/2023 - 11/2002
8Tension-Type Headache (Tension Headache)
08/2022 - 10/2007
8Cerebral Hemorrhage
01/2020 - 03/2007
8Epilepsy (Aura)
10/2019 - 01/2002
8Infarction (Infarctions)
08/2019 - 01/2002
7Peripheral Arterial Disease
01/2022 - 09/2001
7Nausea
07/2021 - 01/2002
7Cerebrovascular Disorders (Cerebrovascular Occlusion)
01/2019 - 01/2004
6Thrombosis (Thrombus)
01/2024 - 01/2004
6Venous Thrombosis (Deep-Vein Thrombosis)
01/2022 - 01/2007
6Cardiovascular Diseases (Cardiovascular Disease)
03/2015 - 03/2005
5Coronary Artery Disease (Coronary Atherosclerosis)
11/2022 - 10/2015
5Patent Foramen Ovale
01/2021 - 01/2012
5Diabetes Mellitus
01/2020 - 07/2010
5Cognitive Dysfunction
03/2015 - 12/2003
4Carotid Stenosis (Carotid Artery Stenosis)
11/2022 - 01/2007
4Hyperacusis (Phonophobia)
07/2021 - 01/2002
4Photophobia (Light Sensitivity)
07/2021 - 01/2002
4Heart Failure
10/2020 - 01/2007
4Vascular Diseases (Vascular Disease)
01/2020 - 08/2004
4Headache Disorders (Headache Syndromes)
01/2019 - 11/2010
4Coronary Disease (Coronary Heart Disease)
01/2017 - 09/2001
4Hemorrhagic Stroke
12/2012 - 03/2007
3Brain Infarction
01/2024 - 08/2016
3Dizziness (Lightheadedness)
06/2023 - 10/2010
3Intracranial Sinus Thrombosis (Sinus Thrombosis)
01/2022 - 10/2018

Drug/Important Bio-Agent (IBA)

59Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
06/2022 - 09/2001
47AnticoagulantsIBA
01/2023 - 02/2005
38Vitamin KFDA Link
04/2024 - 10/2010
37DabigatranFDA Link
04/2024 - 09/2009
29Warfarin (Coumadin)FDA LinkGeneric
01/2022 - 09/2001
26Tryptamines (Triptans)IBA
01/2023 - 01/2002
24Clopidogrel (Plavix)FDA Link
01/2019 - 09/2001
20Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
01/2022 - 09/2001
18Tissue Plasminogen Activator (Alteplase)FDA Link
01/2022 - 10/2002
17Dipyridamole (Persantine)FDA LinkGeneric
01/2019 - 09/2001
16Type A Botulinum Toxins (Botox)FDA Link
07/2023 - 01/2008
15Topiramate (Topamax)FDA LinkGeneric
08/2022 - 08/2004
15Pain-FreeIBA
05/2017 - 02/2004
14Caffeine (No Doz)FDA LinkGeneric
12/2023 - 01/2002
14Analgesics (Analgesic Drugs)IBA
01/2023 - 08/2004
12Calcitonin Gene-Related PeptideIBA
11/2023 - 03/2004
11N(4)-oleylcytosine arabinosideIBA
08/2021 - 07/2013
10Monoclonal AntibodiesIBA
11/2023 - 06/2017
9apixabanIBA
05/2022 - 03/2011
9Telmisartan (Micardis)FDA Link
03/2015 - 01/2007
8Sumatriptan (Imigran)FDA LinkGeneric
01/2021 - 01/2002
7Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA
10/2023 - 04/2011
7preemptIBA
12/2020 - 06/2010
7salicylhydroxamic acid (SHAM)IBA
10/2019 - 04/2006
7Angiotensin Receptor AntagonistsIBA
11/2009 - 03/2005
6eptinezumabIBA
01/2023 - 01/2020
6erenumabIBA
01/2023 - 01/2019
6ThrombinFDA Link
11/2021 - 02/2012
6edoxabanIBA
01/2021 - 01/2017
6Acetaminophen (Paracetamol)FDA LinkGeneric
10/2017 - 05/2009
6Neuroprotective AgentsIBA
08/2011 - 12/2006
6almotriptan (Axert)FDA Link
10/2007 - 01/2005
5Factor Xa InhibitorsIBA
04/2024 - 03/2012
5fremanezumabIBA
11/2023 - 11/2015
5RivaroxabanIBA
06/2022 - 04/2012
5zolmitriptan (Zomig)FDA Link
01/2021 - 01/2005
5eletriptan (Relpax)FDA Link
04/2011 - 01/2002
5Free RadicalsIBA
06/2008 - 02/2006
5disufenton sodium (NXY 059)IBA
06/2008 - 02/2006
4Amitriptyline (Elavil)FDA LinkGeneric
01/2023 - 01/2008
4Anticonvulsants (Antiepileptic Drugs)IBA
01/2023 - 05/2005
4Ibuprofen (Motrin)FDA LinkGeneric
10/2017 - 03/2006
4Antihypertensive Agents (Antihypertensives)IBA
09/2012 - 12/2003
4AntithrombinsIBA
11/2011 - 02/2005
3idarucizumabIBA
01/2023 - 01/2017
3Opioid Analgesics (Opioids)IBA
08/2022 - 02/2012
3LipidsIBA
05/2022 - 07/2006
3Apolipoproteins B (ApoB)IBA
05/2022 - 07/2010
3lasmiditanIBA
01/2022 - 10/2010

Therapy/Procedure

117Therapeutics
03/2024 - 01/2002
30Secondary Prevention
01/2022 - 09/2001
15Thrombectomy
01/2022 - 07/2013
8Stents
01/2017 - 05/2005
6Drug Therapy (Chemotherapy)
01/2023 - 07/2010
5Vagus Nerve Stimulation
10/2020 - 01/2016
5Contraindications
01/2020 - 08/2018
4Aftercare (After-Treatment)
05/2022 - 10/2002
4Electric Countershock (Cardioversion)
01/2021 - 10/2015
3Length of Stay
04/2024 - 08/2010